AU6694298A - Compositions for the treatment of climacteric disorders with nitric oxide synthase substrates and/or donors, in combination with partial estrogen anta gonists - Google Patents

Compositions for the treatment of climacteric disorders with nitric oxide synthase substrates and/or donors, in combination with partial estrogen anta gonists

Info

Publication number
AU6694298A
AU6694298A AU66942/98A AU6694298A AU6694298A AU 6694298 A AU6694298 A AU 6694298A AU 66942/98 A AU66942/98 A AU 66942/98A AU 6694298 A AU6694298 A AU 6694298A AU 6694298 A AU6694298 A AU 6694298A
Authority
AU
Australia
Prior art keywords
donors
compositions
treatment
combination
nitric oxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU66942/98A
Inventor
Kristof Chwalisz
Robert E Garfield
Christa Hegele-Hartung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
University of Texas System
Original Assignee
Schering AG
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG, University of Texas System filed Critical Schering AG
Publication of AU6694298A publication Critical patent/AU6694298A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU66942/98A 1997-03-10 1998-03-10 Compositions for the treatment of climacteric disorders with nitric oxide synthase substrates and/or donors, in combination with partial estrogen anta gonists Abandoned AU6694298A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81291097A 1997-03-10 1997-03-10
US08812910 1997-03-10
PCT/US1998/004586 WO1998040076A1 (en) 1997-03-10 1998-03-10 Compositions for the treatment of climacteric disorders with nitric oxide synthase substrates and/or donors, in combination with partial estrogen antagonists

Publications (1)

Publication Number Publication Date
AU6694298A true AU6694298A (en) 1998-09-29

Family

ID=25210940

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66942/98A Abandoned AU6694298A (en) 1997-03-10 1998-03-10 Compositions for the treatment of climacteric disorders with nitric oxide synthase substrates and/or donors, in combination with partial estrogen anta gonists

Country Status (2)

Country Link
AU (1) AU6694298A (en)
WO (1) WO1998040076A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
HUP0401268A2 (en) 2001-07-31 2004-11-29 Pfizer Products Inc. Pharmaceutical compositions comprising combinations of estrogen agonists/antagonists, estrogens and progestins and process for their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595970A (en) * 1993-07-16 1997-01-21 Schering Aktiengesellschaft Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors

Also Published As

Publication number Publication date
WO1998040076A1 (en) 1998-09-17

Similar Documents

Publication Publication Date Title
AU6693898A (en) Composition for the treatment of male climacteric disorders with nitric oxide s ynthase substrates and/or donors, in combination with androgens and/or arom atase inhibitors
ZA981132B (en) Methods, compositions and articles for reducing or preventing the effects of inflammation.
HU9601301D0 (en) Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
HUP9903515A3 (en) 21-substituted progesterone derivatives as new antiprogestational agents medicoments containing the same, use thereof
ZA987540B (en) Process for the preparation of stanol esters, and use thereof.
IL136938A0 (en) 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
IL138280A0 (en) 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
AU9336098A (en) The use of steroid saponin compounds to prevent senility, and novel steroid saponin compounds
NZ514350A (en) Compositions and methods for effecting the levels of cholesterol
IL146230A0 (en) 3α-HYDROXY-3β-METHOXYMETHYL-SUBSTITUTED STEROIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
HU0500549D0 (en) Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
IL104915A0 (en) Pharmaceutical composition containing estrogen,progestin and antiprogestin and kits containing the same
AU8693098A (en) Compositions and methods for treating diabetes
AUPQ127399A0 (en) Compositions and methods for treating or preventing osteoporosis
AU4813197A (en) Compositions and methods for treating viral infections
AU3063597A (en) Polyalkylphenoxyaminoalkanes and fuel compositions containing the same
EP1121941A4 (en) Sorbefacients and preparations for percutaneous absorption containing the same
AP2000002010A0 (en) Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof
AU1800600A (en) Ume extract having medicinal effects and compositions containing the same
AU4684000A (en) Compositions containing tetracyclines for treating hemorrhagic virus infections and other disorders
AU4392199A (en) Medicinal compositions for treating evacuatory insufficiency
EP0700684A3 (en) Composition containing prothrombincomplex-concentrate and at least one additional component which activates the coagulation, as antidote for blood-anticoagulants
IL145520A0 (en) Flame-retarding composition and process for the preparation thereof
AU7261898A (en) Methods for viral inactivation and compositions for use in same